September 12, 2014
The Pharmaceuticals and Medical Devices Agency (PMDA) issued an alert on its website on September 11 regarding the use of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors in women who are pregnant or may be pregnant. Package inserts...read more